TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event

Growth

Ben Bennett: Focus List

69 Hits · last calculated September 19, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 69 hits from US

Methodology & criteria

Ben Bennett's Focus List: quality growth stocks in strong industries. The industry ranks in the top 40 by 12-month strength, expected earnings per share (EPS) growth for next year is above 25%, revenue grew by an average of more than 30% over the last 2 quarters, price above $10, and sufficiently liquid (~250K shares).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(15)
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Liquidity
How easily a stock can be bought and sold without moving the price - measured by (dollar) volume. Illiquid stocks have wide spreads and jerky prices; that is why almost every scanner applies a minimum liquidity filter.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Ben Bennett: Focus List
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
MXL MaxLinear Inc 07/22 +69 % ⚠ Wildest 10% 113 % Stage 2 B 64 4 of 9 7.3 $ Semiconductors Sells AI Technology 81.10 $ +411.1 % +518.4 % +364.1 % −11.1 % +26.1 % 99 8 10.9 % 11.9 % 3.95 25.1 12.8 14.3 2,203.0 0.39 12.3 -12.2 % 57.5 % -18.2 % -27.9 % -4.9 % 0.33 58.9 % +29.7 % 4 0.0 % 0.0 % 2.4 87.4 % 6.9 % 4.2 (11)
AXTI AXT Inc 07/30 +758 % ⚠ Wildest 10% 152 % Stage 2 A 79 6 of 9 4.6 $ Semiconductor Equipment & Materials Technology 70.00 $ +376.5 % +376.1 % +1,619.5 % −51.8 % +35.1 % 99 13 14.0 % 14.6 % 1.92 24.3 36.5 16.7 12.09 228.3 32.2 % 3.2 % -5.0 % 0.3 % 0.26 -11.1 % 4 0.0 % 0.0 % 7.6 58.1 % 14.6 % 4.8 (5)
TTMI TTM Technologies Inc 07/29 +498 % 81 % Stage 2 B 66 6 of 9 12.3 $ Electronic Components Technology 118.00 $ +208.9 % +157.3 % +134.1 % −5.9 % +89.3 % 98 50 7.5 % 8.3 % 2.15 96.4 5.6 3.6 10.1 0.36 30.2 8.6 % 21.2 % 7.0 % 11.4 % 5.3 % 0.90 46.2 % +19.0 % 6 0.0 % 0.0 % 7.0 96.0 % 4.4 % 4.8 (4)
VIAV Viavi Solutions Inc 08/06 +127 % 75 % Stage 2 B 56 4 of 9 8.9 $ Communication Equipment Sells AI Technology 35.40 $ +180.4 % +159.6 % +184.8 % −16.5 % +77.0 % 98 9 8.6 % 8.4 % 1.23 20.4 5.8 10.4 107.2 1.34 49.8 12.2 % 60.9 % -2.0 % -7.0 % 4.6 % 7.85 33.5 % +8.4 % 7 0.0 % 0.0 % -85.0 97.3 % 5.4 % 3.8 (9)
AAOI Applied Optoelectronics, Inc. 08/06 +1,099 % ⚠ Wildest 10% 140 % Stage 2 C 53 4 of 9 8.4 $ Communication Equipment Sells AI Technology 105.20 $ +322.9 % +266.1 % +232.8 % −40.7 % +66.6 % 98 42 12.0 % 12.7 % 3.78 84.0 14.2 7.7 0.78 38.4 -8.6 % 28.9 % -9.6 % -6.1 % -2.7 % 0.16 70.6 % +82.8 % 5 0.0 % 0.0 % 7.6 68.3 % 14.8 % 4.2 (5)
AIP Arteris Inc 08/04 +177 % 83 % Stage 2 C 45 3 of 9 1.1 $ Semiconductors Sells AI Technology 22.30 $ +165.9 % +197.1 % +142.4 % −3.8 % +83.0 % 98 42 7.1 % 7.5 % 1.91 144.9 12.5 361.4 157.3 -7.7 -38.0 % 87.6 % -46.7 % -1,369.6 % -14.2 % 2.11 1.8 % +22.3 % 6 0.0 % 0.0 % -3.7 61.1 % 6.3 % 4.5 (4)
CIEN Ciena Corp +340 % 73 % Stage 2 A 77 7 of 9 49.4 $ Communication Equipment Technology 348.80 $ +96.6 % +99.3 % +152.7 % −24.0 % +46.0 % 97 98 7.8 % 7.5 % 1.31 115.4 37.0 8.2 17.1 68.7 0.53 47.4 15.2 % 44.1 % 10.9 % 15.5 % 7.7 % 0.67 47.9 % +18.8 % 5 0.0 % 0.0 % 5.8 98.0 % 3.7 % 4.1 (16)
STRL Sterling Construction Company Inc 11/02 +532 % 85 % Stage 2 A 84 7 of 9 16.6 $ Engineering & Construction Uses AI Industrials 518.70 $ +191.4 % +159.2 % +48.8 % −12.3 % +81.5 % 97 88 7.1 % 7.5 % 1.85 43.0 18.0 4.8 12.4 34.6 0.58 20.2 17.2 % 23.8 % 12.6 % 36.7 % 14.5 % 0.57 42.7 % +17.7 % 5 0.0 % 0.0 % 6.7 95.7 % 4.6 % 5.0 (3)
KLIC Kulicke and Soffa Industries Inc 08/05 +47 % 57 % Stage 2 A 77 6 of 9 4.4 $ Semiconductor Equipment & Materials Neutral Technology 83.10 $ +180.3 % +179.3 % +101.7 % −1.4 % +30.2 % 97 6 7.6 % 6.8 % 1.62 76.3 11.7 4.6 5.1 109.0 2.38 22.7 15.9 % 52.6 % 12.2 % 6.4 % 9.0 % 0.05 72.3 % -7.4 % 4 1.0 % 31.5 % 13.9 93.1 % 4.9 % 4.0 (5)
COHU Cohu Inc 07/30 +21 % 69 % Stage 2 B 66 6 of 9 2.7 $ Semiconductor Equipment & Materials Sells AI Technology 57.80 $ +176.6 % +189.3 % +150.7 % −5.0 % +28.9 % 97 5 7.9 % 7.4 % 1.59 26.1 5.2 3.5 78.2 1.15 102.9 -8.3 % 44.0 % -7.4 % -7.0 % -1.8 % 0.43 62.3 % +12.7 % 4 0.0 % 0.0 % 8.6 109.5 % 22.2 % 4.6 (5)
QUIK QuickLogic Corporation 08/11 +46 % 83 % Stage 2 C 49 7 of 9 0.2 $ Semiconductors Technology 10.70 $ +231.7 % +196.4 % +90.2 % −24.3 % +130.0 % 97 42 8.5 % 9.5 % 1.20 114.9 11.7 5.30 20.7 27.3 % -80.1 % -49.2 % -15.1 % -31.5 % 3 0.0 % 0.0 % -28.1 28.3 % 9.4 % 5.0 (2)
CRDO Credo Technology Group Holding Ltd 09/02 +487 % ⚠ Wildest 10% 96 % Stage 2 A 85 7 of 9 32.7 $ Semiconductors Sells AI Technology 175.90 $ +89.0 % +63.6 % +2.1 % −13.2 % +74.9 % 96 93 10.5 % 11.3 % 3.23 67.1 23.9 20.6 15.0 74.6 49.5 35.7 % 67.1 % 33.8 % 34.4 % 16.1 % 0.01 89.9 % +205.7 % 9 0.0 % 0.0 % 19.7 75.9 % 4.0 % 4.6 (13)
AGX Argan Inc +629 % 76 % Stage 2 A 77 5 of 9 5.9 $ Engineering & Construction Uses AI Industrials 389.90 $ +135.6 % +141.6 % +60.7 % −4.8 % +49.6 % 96 86 7.0 % 7.0 % 0.57 34.4 16.6 4.9 11.4 10.8 23.2 15.6 % 20.7 % 15.1 % 38.5 % 10.0 % 36.8 % +8.1 % 8 0.7 % 15.8 % 8.1 108.9 % 7.8 % 4.0 (2)
TVTX Travere Therapeutics Inc 08/05 +82 % 62 % Stage 2 B 56 5 of 9 5.8 $ Biotechnology Uses AI Healthcare 62.80 $ +46.4 % +44.7 % +173.7 % −1.8 % +14.7 % 96 42 3.6 % 4.6 % 1.06 41.7 9.7 57.5 81.1 1,042.1 -29.0 % 59.2 % -7.4 % -69.4 % -3.7 % 3.35 17.8 % +110.5 % 6 0.0 % 0.0 % -2.7 113.4 % 16.6 % 4.6 (15)
ANAB AnaptysBio Inc 08/05 +114 % 68 % Stage 2 C 47 3 of 9 1.6 $ Biotechnology Healthcare 55.20 $ +83.9 % +97.9 % +316.9 % −18.6 % +62.7 % 96 42 5.8 % 5.3 % 0.41 19.1 7.0 127.5 371.6 23.0 -135.5 % 44.6 % -11.5 % -114.6 % 6.8 % 21.76 3.9 % +157.0 % 8 0.0 % 0.0 % 1.7 104.2 % 40.7 % 4.4 (12)
SITM Sitime Corporation 08/05 +172 % 84 % Stage 2 A 82 7 of 9 17.3 $ Semiconductors Sells AI Technology 614.30 $ +100.1 % +87.9 % +115.2 % −25.1 % +57.2 % 95 12 8.0 % 7.5 % 2.86 40.8 36.9 13.9 205.2 3.82 355.9 -4.2 % 58.7 % 3.0 % -2.6 % 0.0 % 0.00 89.6 % +61.2 % 5 0.0 % 0.0 % 16.1 89.0 % 4.9 % 3.9 (7)
SKYT Skywater Technology Inc 08/05 +114 % ⚠ Wildest 10% 90 % Stage 2 B 66 4 of 9 1.6 $ Semiconductors Neutral Technology 32.50 $ +101.2 % +99.1 % +239.9 % −12.9 % +7.7 % 95 99 5.1 % 4.8 % 3.27 14.2 185.2 2.6 8.9 11.8 -3.3 % 20.2 % 18.4 % 95.9 % 0.3 % 1.32 24.6 % +29.2 % 4 0.0 % 0.0 % 2.8 61.4 % 7.3 % 4.2 (5)
LSCC Lattice Semiconductor Corporation 08/03 +23 % 60 % Stage 2 B 74 6 of 9 16.3 $ Semiconductors Sells AI Technology 111.00 $ +96.5 % +91.7 % +62.2 % −8.2 % +54.8 % 94 93 6.8 % 6.5 % 1.78 785.0 33.9 25.1 19.5 79.2 0.59 151.8 15.6 % 69.0 % 5.6 % 2.8 % 3.9 % 0.09 82.3 % +2.7 % 5 0.0 % 0.0 % 11.3 108.6 % 7.7 % 4.5 (14)
OSCR Oscar Health Inc 08/05 +84 % 69 % Stage 2 B 64 7 of 9 9.2 $ Healthcare Plans Uses AI Healthcare 32.10 $ +108.3 % +97.3 % +80.0 % −5.6 % -4.1 % 94 87 5.6 % 6.6 % 2.37 588.2 0.6 6.1 2.1 0.0 15.2 % 20.2 % 3.6 % -2.6 % 4.5 % 0.26 17.9 % +27.5 % 4 0.0 % 0.0 % 3.0 67.6 % 6.5 % 3.3 (7)
URGN UroGen Pharma Ltd 08/06 +18 % 65 % Stage 2 B 63 3 of 9 2.1 $ Biotechnology Uses AI Healthcare 43.30 $ +50.1 % +51.8 % +142.8 % −4.7 % +36.4 % 94 42 5.1 % 5.4 % 1.58 36.6 11.0 -2.6 -39.8 % 90.9 % -51.7 % -1,481.3 % -18.1 % -49.0 % +21.5 % 4 0.0 % 0.0 % -8.0 100.6 % 13.0 % 4.4 (8)
LASR nLIGHT Inc 08/06 +113 % ⚠ Wildest 10% 88 % Stage 2 B 74 7 of 9 2.2 $ Semiconductors Technology 39.80 $ +77.1 % +65.4 % +30.2 % −28.2 % +131.4 % 93 42 7.4 % 8.0 % 2.30 56.5 7.2 5.0 53.9 1.78 580.1 -0.5 % 31.5 % -4.0 % -4.6 % -2.2 % 0.08 83.2 % +31.6 % 4 0.0 % 0.0 % 11.0 92.1 % 6.4 % 4.6 (7)
OUST Ouster, Inc. 08/06 +244 % ⚠ Wildest 10% 105 % Stage 2 B 59 6 of 9 2.4 $ Electronic Components Sells AI Technology 35.10 $ +108.7 % +141.8 % +14.2 % −18.8 % +69.7 % 93 42 15.3 % 13.5 % 3.25 0.0 11.5 -0.8 -39.6 % 46.6 % -26.0 % -25.2 % -10.7 % 72.2 % +52.5 % 5 0.0 % 0.0 % -0.7 50.0 % 9.9 % 4.3 (6)
SEI Solaris Energy Infrastructure, Inc 07/22 +327 % 78 % Stage 2 B 69 5 of 9 6.9 $ Oil & Gas Equipment & Services Sells AI Energy 69.70 $ +70.3 % +76.6 % +109.9 % −7.8 % +39.3 % 92 87 7.0 % 7.1 % 1.26 384.6 9.0 0.94 23.5 25.8 % 49.9 % 7.2 % 8.7 % 4.1 % 26.1 % +98.7 % 5 0.8 % 43.2 % 4.1 113.1 % 23.8 % 4.9 (8)
AXSM Axsome Therapeutics Inc 08/03 +58 % 42 % Stage 2 C 51 5 of 9 11.0 $ Biotechnology Healthcare 207.80 $ +32.5 % +56.9 % +83.7 % −8.8 % +34.6 % 92 42 3.6 % 3.5 % 0.71 33.9 14.2 196.7 -14.8 -32.8 % 93.2 % -24.7 % -349.4 % -16.3 % 4.03 7.6 % +65.6 % 7 0.0 % 0.0 % -3.1 76.6 % 9.1 % 4.7 (19)
TGTX TG Therapeutics Inc 08/03 +43 % 45 % Stage 2 B 65 5 of 9 8.8 $ Biotechnology Neutral Healthcare 56.90 $ +80.9 % +79.3 % +76.3 % −6.5 % +23.4 % 90 92 5.0 % 4.8 % 1.66 20.4 24.6 11.0 15.3 502.1 1.61 59.7 17.0 % 82.4 % 55.2 % 112.6 % 7.3 % 1.29 38.1 % +87.3 % 6 0.0 % 0.0 % 6.2 70.2 % 28.5 % 4.3 (9)
IOVA Iovance Biotherapeutics Inc 08/06 -15 % ⚠ Wildest 10% 95 % Stage 2 B 61 5 of 9 4.4 $ Biotechnology Neutral Healthcare 10.30 $ +62.6 % +46.7 % +351.4 % −25.2 % +0.0 % 90 42 7.9 % 8.3 % 0.83 0.0 13.6 -8.7 48.4 % -89.1 % -47.5 % -20.3 % +60.6 % 5 0.0 % 0.0 % -3.3 67.5 % 20.8 % 4.1 (12)
AVT Avnet Inc 08/05 +35 % 37 % Stage 2 B 64 5 of 9 7.9 $ Electronics & Computer Distribution Neutral Technology 96.10 $ +88.1 % +79.7 % +81.7 % −4.7 % +14.1 % 89 60 3.2 % 3.6 % 1.12 34.8 7.1 0.3 1.6 2.65 12.8 3.1 % 10.4 % 1.2 % 4.4 % 3.9 % 0.77 36.7 % -6.6 % 3 1.6 % 25.1 % 7.8 110.1 % 11.2 % 2.8 (5)
CYTK Cytokinetics Inc 08/06 +8 % 44 % Stage 2 D 41 3 of 9 9.2 $ Biotechnology Neutral Healthcare 68.80 $ +25.9 % +36.0 % +47.0 % −2.6 % +57.2 % 88 42 4.6 % 4.1 % 0.36 117.6 136.5 52.2 -15.8 -948.7 % -498.7 % 0.0 % -572.2 % -28.1 % -1.56 -64.9 % +376.6 % 3 0.0 % 0.0 % -7.3 118.8 % 19.2 % 4.3 (21)
MIRM Mirum Pharmaceuticals Inc 08/05 +102 % 46 % Stage 2 D 37 3 of 9 5.4 $ Biotechnology Healthcare 91.80 $ +40.6 % +52.3 % +35.1 % −1.9 % +39.9 % 86 42 5.0 % 5.0 % 0.49 172.4 8.8 24.0 341.2 -39.5 % 81.7 % -139.2 % -335.8 % -6.8 % 1.34 27.2 % +54.7 % 7 0.0 % 0.0 % -5.4 114.4 % 12.2 % 4.6 (10)
HLIT Harmonic Inc 07/27 -4 % 51 % Stage 2 C 50 4 of 9 1.2 $ Communication Equipment Threatened Technology 11.10 $ +48.2 % +58.1 % +9.6 % −31.5 % +46.8 % 86 72 4.9 % 6.8 % 1.32 139.9 18.8 2.4 3.5 926.9 1.84 18.6 16.8 % 50.0 % -10.6 % 2.1 % 4.7 % 0.31 53.3 % -46.9 % 4 0.0 % 0.0 % -0.8 89.0 % 7.5 % 3.6 (7)
SSRM SSR Mining Inc 08/04 +38 % 69 % Stage 2 B 69 6 of 9 7.5 $ Gold Basic Materials 36.30 $ +33.5 % +24.4 % +66.1 % −22.1 % +14.7 % 83 98 6.6 % 5.9 % 0.98 14.1 8.5 3.9 2.0 21.7 0.02 6.6 52.5 % 55.0 % 12.3 % 12.4 % 9.2 % 0.02 61.1 % +66.6 % 6 0.1 % 1.0 % 10.1 75.7 % 4.6 % 3.4 (9)
MCHP Microchip Technology Inc 08/06 +8 % 50 % Stage 2 B 74 6 of 9 43.8 $ Semiconductors Technology 73.30 $ +48.0 % +37.8 % +13.5 % −11.1 % +56.1 % 82 6 6.1 % 5.6 % 1.74 305.5 19.4 8.5 5.7 39.4 0.21 30.1 17.1 % 60.2 % 9.3 % 3.4 % 3.5 % -21.04 44.8 % +7.1 % 3 2.6 % 92.4 % 6.1 100.6 % 8.1 % 4.3 (24)
FN Fabrinet 08/17 +123 % 75 % Stage 2 B 74 7 of 9 14.7 $ Electronic Components Technology 388.60 $ +28.2 % +9.7 % +6.3 % −24.2 % +86.9 % 82 78 7.4 % 7.8 % 1.21 31.2 12.8 3.2 5.7 3,424.7 1.19 20.6 9.9 % 12.0 % 10.2 % 20.0 % 8.6 % 0.00 65.7 % +18.6 % 6 0.0 % 0.0 % 11.7 113.6 % 5.6 % 3.9 (9)
ARQT Arcutis Biotherapeutics Inc 08/05 +66 % 56 % Stage 3 B 74 6 of 9 3.2 $ Biotechnology Healthcare 25.40 $ -9.5 % -9.1 % +54.4 % −16.0 % +39.2 % 77 42 4.7 % 4.6 % 1.50 23.5 6.9 16.7 82.6 62.4 -8.6 % 91.1 % 6.2 % -1.4 % 5.1 % 0.07 41.2 % +91.3 % 6 0.0 % 0.0 % -0.1 110.2 % 14.1 % 4.6 (7)
FENC Fennec Pharmaceuticals Inc 08/13 +5 % 65 % Stage 2 B 63 8 of 9 0.4 $ Biotechnology Healthcare 10.60 $ +33.8 % +43.8 % +24.3 % −0.4 % +66.7 % 76 42 5.4 % 5.6 % 1.10 10.9 6.4 10.1 1.47 20.3 93.7 % -5.5 % -52.7 % -1.2 % -6.1 % 6 0.0 % 0.0 % -1.4 54.3 % 1.7 % 4.6 (5)
CURB Curbline Properties Corp. 07/27 20 % Stage 2 B 59 4 of 9 2.9 $ REIT - Retail Real Estate 28.30 $ +35.2 % +36.1 % +31.6 % −0.7 % +17.9 % 75 9 2.2 % 2.3 % 50.5 14.5 24.3 25.4 13.1 % 75.2 % 13.1 % 1.7 % 1.0 % 72.3 % +51.3 % 8 2.3 % 130.2 % 6.8 119.7 % 23.0 % 3.4 (9)
KURA Kura Oncology Inc 08/06 -2 % 59 % Stage 3 D 41 2 of 9 1.0 $ Biotechnology Neutral Healthcare 11.70 $ -0.1 % -0.8 % +44.9 % −17.1 % +173.5 % 75 42 5.3 % 6.1 % 0.43 0.0 13.6 9.5 -2.5 -236.7 % 0.0 % -124.7 % -31.3 % 0.23 +25.2 % 4 0.0 % 0.0 % -0.6 96.4 % 15.5 % 4.5 (15)
HL Hecla Mining Company 08/05 +69 % 74 % Stage 1 B 68 6 of 9 13.4 $ Other Precious Metals & Mining Basic Materials 18.90 $ -21.4 % -22.3 % +72.1 % −55.7 % +29.9 % 73 97 6.1 % 5.9 % 1.38 27.2 26.5 8.4 4.9 26.1 5.64 12.9 55.5 % 61.4 % 19.2 % 19.9 % 15.3 % 0.10 76.1 % +53.0 % 8 0.1 % 2.1 % 9.3 76.5 % 0.0 % 3.9 (10)
RYZ Ryerson Holding Corporation 08/04 -7 % 50 % Stage 2 B 57 5 of 9 1.3 $ Metal Fabrication Industrials 24.30 $ +11.0 % -2.0 % +11.6 % −10.0 % +20.8 % 73 50 4.6 % 4.2 % 1.58 3.5 0.2 0.9 21.8 2.2 % 17.3 % -0.6 % -4.3 % 0.5 % 1.01 34.4 % -0.6 % 2 3.0 % 118.7 % 6.4 96.0 % 3.6 %
RYTM Rhythm Pharmaceuticals Inc 08/04 +170 % 47 % Stage 3 B 55 5 of 9 6.6 $ Biotechnology Healthcare 97.70 $ -0.8 % -2.0 % +3.0 % −11.4 % +40.8 % 70 42 5.8 % 4.8 % 1.97 526.3 27.7 54.2 -12.6 -87.1 % 89.0 % -85.6 % -101.2 % -31.0 % 1.85 27.8 % +45.8 % 5 0.0 % 0.0 % -4.6 110.0 % 15.1 % 4.7 (12)
MDGL Madrigal Pharmaceuticals Inc 08/04 +39 % 44 % Stage 2 B 58 2 of 9 12.4 $ Biotechnology Healthcare 531.50 $ -11.8 % -12.5 % +28.0 % −16.5 % +28.2 % 68 42 4.0 % 4.0 % -0.99 82.0 9.7 22.4 -8.3 -29.8 % 91.5 % -25.3 % -49.4 % -17.8 % 0.64 44.3 % +432.1 % 4 0.0 % 0.0 % 1.3 106.5 % 11.4 % 4.5 (15)
EE Excelerate Energy Inc 08/10 +28 % 37 % Stage 2 B 61 3 of 9 4.1 $ Oil & Gas Midstream Energy 36.00 $ +29.1 % +32.5 % +54.2 % −13.4 % +19.2 % 68 23 3.5 % 3.3 % 1.22 29.7 0.0 2.8 1.6 625.2 4.4 37.5 % 3.2 % 7.9 % 5.0 % 2.05 +44.3 % 3 1.0 % 22.3 % 5.0 105.8 % 11.8 % 3.4 (9)
SNDX Syndax Pharmaceuticals Inc 08/03 -2 % 50 % Stage 1 B 64 3 of 9 1.6 $ Biotechnology Healthcare 17.60 $ -6.7 % +0.8 % +19.9 % −22.6 % +112.1 % 63 42 4.7 % 4.4 % 0.37 0.0 6.3 -105.3 -52.7 % -8.0 % -87.5 % -189.5 % -18.7 % 8.8 % +627.8 % 4 0.0 % 0.0 % -4.3 116.0 % 24.7 % 4.7 (12)
ASTS Ast Spacemobile Inc 08/10 +321 % ⚠ Wildest 10% 111 % Stage 1 C 52 5 of 9 22.8 $ Communication Equipment Technology 58.50 $ +0.3 % +11.2 % +52.3 % −51.0 % +34.2 % 62 42 10.4 % 11.6 % 2.73 0.0 198.0 8.5 -2.3 -1,014.0 % 38.9 % 0.0 % -37.8 % -7.6 % 1.44 34.4 % +1,505.2 % 5 0.0 % 0.0 % 5.9 47.2 % 21.5 % 3.2 (11)
BBIO BridgeBio Pharma Inc 08/04 +113 % 47 % Stage 1 B 58 3 of 9 13.0 $ Biotechnology Healthcare 66.60 $ -10.3 % -5.9 % +31.5 % −18.0 % +59.7 % 59 42 3.7 % 4.0 % 0.97 0.0 18.3 119.2 -9.4 -54.5 % 94.4 % -97.0 % -1,789.7 % -26.0 % -1.49 -165.5 % +126.3 % 4 0.0 % 0.0 % -7.9 103.2 % 12.5 % 4.4 (19)
TARS Tarsus Pharmaceuticals Inc 08/05 +88 % 46 % Stage 4 B 59 3 of 9 3.2 $ Biotechnology Healthcare 78.10 $ -19.2 % -25.8 % +52.9 % −24.5 % +21.7 % 56 42 4.6 % 4.6 % 0.54 71.9 5.3 9.3 57.7 -3.2 -3.8 % 82.7 % -7.7 % -14.0 % -5.5 % 0.25 60.1 % +146.7 % 6 0.0 % 0.0 % 6.4 109.8 % 14.2 % 4.6 (8)
ROAD Construction Partners Inc 08/06 +93 % 51 % Stage 3 B 74 6 of 9 5.3 $ Engineering & Construction Industrials 94.30 $ +13.4 % +7.3 % -24.9 % −16.7 % +50.7 % 47 87 5.1 % 5.1 % 0.90 40.2 24.9 1.5 5.3 30.4 1.57 15.2 4.8 % 15.8 % 4.1 % 14.2 % 6.3 % -15.62 28.5 % +54.2 % 6 0.0 % 0.0 % 5.1 104.5 % 7.4 % 4.2 (5)
NBBK NB Bancorp, Inc. 07/22 26 % Stage 2 B 57 4 of 9 1.0 $ Banks - Regional Financial Services 22.80 $ +5.2 % +2.6 % +24.6 % −7.6 % +12.3 % 45 59 2.1 % 2.1 % -0.01 16.7 0.0 1.2 12.6 0.0 100.0 % 23.8 % 6.7 % 0.9 % 0.23 +4.3 % 7 1.2 % 14.8 % 4.3 52.5 % 3.5 % 4.0 (1)
CVI CVR Energy Inc 07/29 +6 % 54 % Stage 4 C 51 5 of 9 5.5 $ Oil & Gas Refining & Marketing Energy 53.70 $ +8.9 % +8.6 % +67.1 % −34.5 % -38.3 % 23 9 4.9 % 5.0 % 0.84 40.5 0.7 14.2 0.71 8.0 10.9 % 0.8 % 4.7 % 5.5 % -5.9 % 3 0.8 % 14.5 % 3.6 102.3 % 18.3 % 2.6 (7)
ALNY Alnylam Pharmaceuticals Inc 07/30 +17 % 51 % Stage 4 A 79 7 of 9 31.8 $ Biotechnology Uses AI Healthcare 239.60 $ -27.5 % -26.7 % -47.0 % −40.8 % +55.1 % 17 42 3.4 % 3.4 % 0.30 60.3 19.6 6.6 29.9 0.32 28.4 23.0 % 79.7 % 16.1 % 90.4 % 12.3 % 1.18 21.0 % +65.2 % 8 0.0 % 0.0 % 4.2 102.1 % 6.3 % 4.2 (30)
VRDN Viridian Therapeutics Inc 08/05 -11 % 74 % Stage 4 B 64 2 of 9 2.5 $ Biotechnology Healthcare 22.00 $ -44.5 % -41.8 % +17.8 % −49.3 % +67.2 % 13 42 5.1 % 5.1 % 0.96 1.0 34.9 4.9 -3.2 -82,389.4 % -356.5 % 0.0 % -58.1 % -30.2 % 0.08 80.6 % +23,359.9 % 6 0.0 % 0.0 % 4.8 109.2 % 17.9 % 4.4 (16)
INSM Insmed Inc 08/06 +45 % 62 % Stage 4 B 66 4 of 9 26.0 $ Biotechnology Healthcare 120.00 $ -41.3 % -41.0 % -14.4 % −50.9 % +62.8 % 12 42 4.8 % 4.9 % 0.82 74.1 22.9 37.8 1.09 -6.0 -65.5 % 83.5 % -76.9 % -294.5 % -22.2 % 1.32 34.0 % +66.7 % 5 0.0 % 0.0 % -4.9 105.7 % 5.9 % 4.8 (21)
CAI Caris Life Sciences, Inc. 08/11 68 % Stage 4 B 72 6 of 9 8.5 $ Biotechnology Healthcare 30.00 $ -34.8 % -35.1 % -7.8 % −56.0 % +5.5 % 11 50 5.9 % 6.5 % 33.3 8.6 17.4 58.1 37.9 2.4 % 69.9 % 10.6 % 28.3 % 8.8 % 0.73 51.1 % +97.0 % 9 0.0 % 0.0 % 2.6 56.7 % 11.9 %
ONC BeiGene, Ltd. 35 % A 77 7 of 9 39.7 $ Biotechnology Healthcare 350.80 $ +18.3 % +3.0 % +2.3 % −4.8 % +23.1 % 0.52 62.6 34.6 6.5 7.7 31.9 0.76 34.1 19.1 % 88.9 % 10.7 % 14.7 % 7.5 % 0.25 53.3 % +40.2 % 8 0.0 % 0.0 % 6.4 33.0 % 1.6 % 4.6 (24)
VG Venture Global, Inc. 80 % B 68 6 of 9 35.1 $ Oil & Gas Midstream Energy 14.00 $ +93.8 % +30.0 % +2.3 % −24.6 % +8.6 % 15.8 15.7 2.3 5.2 1.55 10.2 25.0 % 46.9 % 22.1 % 25.5 % 7.4 % 5.07 12.6 % +176.9 % 5 1.1 % 7.3 % 1.1 93.0 % 78.8 % 4.0 (13)
ASND Ascendis Pharma AS 39 % B 67 5 of 9 15.5 $ Biotechnology Healthcare 236.70 $ +19.4 % +14.7 % +18.7 % −8.2 % +20.9 % 0.49 27.2 24.0 15.6 27.6 321.1 78.2 10.1 % 91.3 % 70.9 % 33.3 % 9.6 % -12.5 % +90.2 % 6 0.0 % 0.0 % 103.9 % 6.7 % 4.8 (16)
BVN Compania de Minas Buenaventura SAA 54 % A 75 7 of 9 8.7 $ Other Precious Metals & Mining Basic Materials 34.30 $ +25.0 % -11.0 % +77.6 % −20.3 % +10.7 % 0.45 8.3 36.5 3.9 2.1 13.3 1.11 6.0 41.9 % 61.2 % 48.2 % 27.8 % 10.8 % 0.17 67.4 % +50.0 % 9 3.3 % 25.0 % 4.4 60.0 % 2.3 % 3.3 (6)
SIMO Silicon Motion Technology 82 % A 78 5 of 9 9.2 $ Semiconductors Technology 272.10 $ +141.6 % +62.8 % +201.9 % −33.5 % +33.1 % 1.70 32.7 18.1 7.0 9.1 0.70 25.3 22.4 % 48.9 % 22.1 % 31.6 % 10.2 % 0.00 68.0 % +10.2 % 6 0.8 % 25.5 % 13.8 82.9 % 5.0 % 4.3 (9)
GGAL Grupo Financiero Galicia SA 67 % D 43 1 of 9 7.1 $ Banks - Regional Financial Services 41.80 $ -17.5 % -10.9 % +59.7 % −26.8 % +50.7 % 0.28 116.2 3.3 0.8 1.2 2.6 0.18 0.0 1.8 % 96.1 % 1.5 % 0.9 % 0.2 % 0.46 17.0 % +16.9 % 3 4.1 % 128.4 % 25.5 % 17.1 % 4.6 (5)
AUGO Aura Minerals Inc. 74 % B 73 5 of 9 7.4 $ Gold Basic Materials 88.30 $ +50.9 % +4.2 % +196.7 % −30.3 % +16.8 % 0.36 24.8 8.8 5.7 16.2 42.2 12.5 51.4 % 60.0 % 23.2 % 100.2 % 29.8 % 1.55 16.5 % +55.1 % 8 3.1 % 76.1 % 3.8 41.5 % 15.7 %
OR Osisko Gold Ro 48 % B 73 7 of 9 6.9 $ Gold Basic Materials 36.70 $ -4.8 % -20.0 % +3.4 % −29.4 % +14.2 % 1.37 24.5 28.5 18.9 4.6 18.8 77.0 % 96.9 % 78.0 % 20.4 % 10.6 % 0.00 90.9 % +47.5 % 7 0.7 % 19.1 % 27.1 90.0 % 1.9 % 4.2 (12)
PAGP Plains GP Holdings LP 19 % C 46 4 of 9 6.5 $ Oil & Gas Midstream Energy 27.70 $ +31.2 % +21.4 % +60.6 % −5.8 % -9.8 % 0.45 79.2 15.2 0.1 4.2 2.9 0.70 4.4 2.6 % 5.6 % 1.1 % 8.3 % 3.4 % 8.39 4.3 % -11.6 % 3 5.8 % 3.0 % 85.1 % 7.6 % 3.8 (13)
EQPT EquipmentShare.com Inc B 60 6 of 9 4.5 $ Rental & Leasing Services Industrials 18.00 $ -39.9 % −43.5 % +88.6 % 199.7 25.5 0.9 3.8 1.28 11.4 0.1 % 36.5 % 0.5 % 1.8 % 3.4 % 6.36 8.8 % +16.4 % 5 0.0 % 0.0 % 1.6 48.6 % 11.6 %
LEGN Legend Biotech Corp 71 % D 41 3 of 9 3.4 $ Biotechnology Healthcare 17.60 $ +0.4 % +27.0 % -49.9 % −42.1 % +156.5 % 0.40 24.1 3.0 3.3 287.0 -16.3 % 56.6 % -7.2 % -25.2 % -1.9 % 0.33 57.8 % +64.0 % 5 0.0 % 0.0 % 2.6 53.7 % 21.9 % 4.5 (22)
SBLK Star Bulk Carriers Corp 33 % B 73 5 of 9 3.6 $ Marine Shipping Industrials 32.50 $ +44.0 % +18.8 % +75.6 % −5.1 % +5.5 % 0.72 12.7 7.2 3.0 1.5 12.7 1.95 8.2 39.7 % 47.3 % 23.9 % 11.7 % 5.4 % 0.45 64.4 % -17.6 % 3 6.1 % 70.4 % 1.7 38.2 % 2.2 % 4.4 (5)
ECO Okeanis Eco Tankers Corp. 43 % A 83 6 of 9 3.3 $ Marine Shipping Industrials 85.00 $ +79.5 % +50.4 % +235.2 % −4.8 % +2.9 % 0.02 7.9 9.8 4.7 3.8 77.8 6.7 75.0 % 51.7 % -8.6 % 25.0 % 8.9 % 0.90 47.7 % -0.4 % 5 13.7 % 88.5 % 3.7 28.7 % 4.6 % 5.0 (1)
MUX McEwen Mining Inc. 67 % B 65 4 of 9 1.2 $ Other Precious Metals & Mining Basic Materials 19.00 $ +3.4 % -28.4 % +39.5 % −34.1 % +59.0 % 1.26 15.1 6.0 4.7 1.7 292.0 20.7 -5.9 % 37.3 % 32.5 % 13.5 % -0.4 % 0.23 66.6 % +13.2 % 4 0.0 % 0.0 % 0.7 60.8 % 22.6 % 4.4 (5)
FPS Forgent Power Solutions, Inc. B 62 7 of 9 12.0 $ Electrical Equipment & Parts Industrials 39.40 $ +12.6 % −41.6 % +105.1 % 1,971.0 29.9 8.5 22.9 0.37 68.3 10.4 % 34.3 % 2.2 % 0.0 % 0.0 % 1.36 24.4 % +315.4 % 0.0 % 0.0 % 78.6 % 19.2 %
FRO Frontline Ltd 43 % B 71 7 of 9 11.5 $ Oil & Gas Midstream Neutral Energy 51.40 $ +74.8 % +31.1 % +145.7 % −11.1 % -2.9 % 0.06 12.8 9.8 5.1 4.1 19.3 5.58 7.5 51.8 % 63.0 % 54.8 % 35.0 % 14.0 % 1.22 43.6 % -4.2 % 4 11.5 % 1.7 % 2.7 36.1 % 6.5 % 4.8 (6)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Ben Bennett's Focus List: quality growth stocks in strong industries. The industry ranks in the top 40 by 12-month strength, expected earnings per share (EPS) growth for next year is above 25%, revenue grew by an average of more than 30% over the last 2 quarters, price above $10, and sufficiently liquid (~250K shares).

All scanners are recalculated daily across the entire stock universe — most recently on September 19, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 69 stocks pass this scanner's criteria (as of September 19, 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?